Biomaterials used for dendritic cell vaccine for cancer immunotherapy
M: Medicine – Surgery – Orthopaedics – Material for disabled
Informations
- Stand number
- E79
- Exhibition class
- M: Medicine – Surgery – Orthopaedics – Material for disabled
- Technical description
- Vaccine which enhances dendritic cell maturation using silica nanomatrices, offering a safe and biocompatible approach to improve treatment efficiency, effectiveness and survival rates in cancer immunotherapy.
- Simplified description
- Traditional cancer treatments usually use strong drugs. A new method uses special particles called silica nanomatrices to boost the body’s immune response safely, improving treatment outcomes and survival rates.
Inventors
The Education University of Hong Kong
inventor 3700503414_2937
Information in this online catalogue is based on data received for the Event and updated by the participant. Catalogue entries remain the sole responsability of the participant. The Exhibition management declines all responsibility for any possible errors or omissions.